Form D · Retailing
Global Farmaceuticals, Inc.
Spokane Valley, WA · CIK 0001633601
Offering snapshot reported Feb 17, 2015 · SEC filing
- Reported sold
- Yet to sell Offering amount: $100K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5K
- Finders' fees
- $0
- Form D file number
- 021-234128
Up to 1,000,000 restricted shares of common stock at $0.10 per share
Pennaluna & Company is paid a commission of 5%
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Pennaluna & Company | 11604 | Ron Nicklas · CRD 1055099 |
Source: Form D, filed Feb 17, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Haakenson | Director, Executive, Promoter |
Issuer details
Industry: Retailing (See others in industry)
Address:
10014 East Montgomery Unit #4
Spokane Valley, WA, 99206
Spokane Valley, WA, 99206